Atea Pharmaceuticals, Inc.
AVIR • NASDAQ
Atea Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jean-Pierre Sommadossi, with a market cap of $407.9M.
Market Cap$407.9M
Employees74.0
CEOJean-Pierre Sommadossi
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · in a monthQ1 2026
Financials
AVI
Atea Pharmaceuticals, Inc. FAQ
Common questions about Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc. is scheduled to report earnings for Q1 2026 on May 11, 2026.
Atea Pharmaceuticals, Inc. has approximately 74 employees.